Transcriptomic analysis delineates potential regulatory network as therapeutic alternatives in chronic myeloid leukemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Transcriptomic analysis delineates potential regulatory network as therapeutic alternatives in chronic myeloid leukemia ; volume:25 ; number:1 ; day:3 ; month:12 ; year:2024 ; pages:1-13 ; date:12.2024
The Egyptian journal of medical human genetics ; 25, Heft 1 (3.12.2024), 1-13, 12.2024
- Creator
-
Tasneem, Alvea
Sharma, Archana
Syed, Mansoor Ali
Dohare, Ravins
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43042-024-00614-2
- URN
-
urn:nbn:de:101:1-2502172139599.677999251523
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tasneem, Alvea
- Sharma, Archana
- Syed, Mansoor Ali
- Dohare, Ravins
- SpringerLink (Online service)
Other Objects (12)
The genomic & transcriptomic landscape of acute myeloid leukemia
Immune-Based Therapeutic Strategies for Acute Myeloid Leukemia
Therapeutic use of Aldara™ in chronic myeloid leukemia
Novel Therapeutic Targets in Acute Myeloid Leukemia (AML)
Chronic myeloid leukemia stem cells: targeting therapeutic implications
RhoA: A therapeutic target for chronic myeloid leukemia
Midostaurin reduces Regulatory T cells markers in Acute Myeloid Leukemia
Therapeutic strategies to improve treatment outcome in acute myeloid leukemia
Mechanistic and therapeutic insights into IDH1 mutant acute myeloid leukemia
Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
Glutamine synthetase : a potential therapeutic target in acute myeloid leukemia
Increased IDO expression and regulatory T cells in acute myeloid leukemia: implications for immune escape and therapeutic targeting
The genomic & transcriptomic landscape of acute myeloid leukemia
Immune-Based Therapeutic Strategies for Acute Myeloid Leukemia
Therapeutic use of Aldara™ in chronic myeloid leukemia
Novel Therapeutic Targets in Acute Myeloid Leukemia (AML)
Chronic myeloid leukemia stem cells: targeting therapeutic implications
RhoA: A therapeutic target for chronic myeloid leukemia
Midostaurin reduces Regulatory T cells markers in Acute Myeloid Leukemia
Therapeutic strategies to improve treatment outcome in acute myeloid leukemia
Mechanistic and therapeutic insights into IDH1 mutant acute myeloid leukemia
Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
Glutamine synthetase : a potential therapeutic target in acute myeloid leukemia
Increased IDO expression and regulatory T cells in acute myeloid leukemia: implications for immune escape and therapeutic targeting
The genomic & transcriptomic landscape of acute myeloid leukemia
Immune-Based Therapeutic Strategies for Acute Myeloid Leukemia
Therapeutic use of Aldara™ in chronic myeloid leukemia
Novel Therapeutic Targets in Acute Myeloid Leukemia (AML)
Chronic myeloid leukemia stem cells: targeting therapeutic implications
RhoA: A therapeutic target for chronic myeloid leukemia
Midostaurin reduces Regulatory T cells markers in Acute Myeloid Leukemia
Therapeutic strategies to improve treatment outcome in acute myeloid leukemia
Mechanistic and therapeutic insights into IDH1 mutant acute myeloid leukemia
Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
Glutamine synthetase : a potential therapeutic target in acute myeloid leukemia